Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
Recruiting · NCT07778810 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain infarction, brain ischemia, brain stem infarction, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 2 | 2026-10-02 | NCT07778810 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 36 |
| Jazz Pharmaceuticals | 60 |
| Johns Hopkins University | 579 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kennedy Krieger Institute | Baltimore | United States | 41 |